Rising Number Of Psychiatric Patients Expected To Drive Panic Disorder Market Growth: Critical Driver Shaping the Panic Disorders Market in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts

Panic Disorders Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size for panic disorders has seen a steady expansion. The market that's valued at $10.73 billion in 2024 is projected to increase to $11.19 billion in 2025, with a compound annual growth rate (CAGR) of 4.3%. Factors such as the use of antidepressant drugs, heightened awareness about mental health, rising levels of stress, greater access to mental health facilities, and improvements in diagnostic standards contributed to the growth during the historical period.

Panic Disorders Market Size Forecast: What's the Projected Valuation by 2029?
The market size for panic disorders is predicted to experience substantial growth in the upcoming years, increasing to $13.96 billion in 2029, with a compound annual growth rate (CAGR) of 5.7%. This expansion during the forecasted period can be credited to the development of new pharmacological treatments, telepsychiatry services, emphasis on addressing comorbidities, global initiatives on mental health, application of pharmacogenomics in treatments, and public outreach education programs. The projected period will also see prominent trends such as digital interventions in mental health, usage of telemedicine for treating panic disorder, advancements in medication, neurological research, and remote monitoring using wearable technology.

View the full report here:
https://www.thebusinessresearchcompany.com/report/panic-disorders-global-market-report

What Are the Drivers Transforming the Panic Disorders Market?
The future growth of the panic disorder market is likely to be driven by a rise in the number of psychiatric patients. Individuals suffering from psychiatric conditions or mental illnesses, such as panic disorder or panic attacks, exhibit disruptions in cognition, emotional and social behavior. Therapeutic approaches, medication, and lifestyle modifications are normally used to treat patients with panic disorder. This helps to alleviate panic attack symptoms, enhance the patient's quality of life, and enable them to effectively manage and cope with their condition. As highlighted in the State of Mental Health in America 2022 report by Mental Health America, a US-based mental health non-profit organization, the number of adults afflicted with any mental illness swelled to 49,564,000, reflecting 19.86% of the entire US population in 2022, up from 47,132,000 or 19.00% in 2021. The rising number of psychiatric patients, therefore, is anticipated to fuel the growth of the panic disorder market. The transformative impact of Telehealth on the panic disorder market is another driving force. As telehealth usage increases, it's set to boost the panic disorder market's growth. Using digital communication tools like videoconferencing, phone calls, and secure messaging, telehealth offers remote healthcare and medical consultations. It particularly aids in providing psychotherapy and counseling services for those plagued by panic disorders by enabling therapists to conduct individual or group therapy sessions or support groups through secure videoconferencing platforms. FAIR Health Inc., a US-based non-profit organization, revealed a 7.3% nationwide surge in telehealth usage in April 2023 - up from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. The increased uptake of telehealth is, thus, stimulating the panic disorder market's growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13191&type=smp

What Long-Term Trends Will Define the Future of the Panic Disorders Market?
Leading businesses in the panic disorder market are prioritizing the creation of innovative treatments, such as prolonged-release capsules, to maintain their industry standing. Long-term release capsules are drugs that gradually release the active ingredients over an extended period, typically 12 to 24 hours, to manage conditions that need prolonged medication. For instance, in May 2023, Granules India Ltd., a pharmaceutical company based in India, secured abbreviated new drug application (ANDA) approval from the US Food & Drug Administration (USFDA) for their creation of Venlafaxine hydrochloride extended-release capsules. These capsules are comparable in bioequivalence to the reference-listed drug product (RLD), namely Effexor XR Extended-Release Capsules, manufactured by Upjohn US 2 LLC. Venlafaxine HCl extended-release capsules are used to treat various conditions like generalized anxiety disorder (GAD), major depressive disorder (MDD), panic disorder (PD), and social anxiety disorder (SAD). These capsules function by amplifying the amount of serotonin and norepinephrine in the brain. The typical starting dosage is 75 mg per day, and it can be increased based on the doctor's discretion.

Which Segments in the Panic Disorders Market Offer the Most Profit Potential?
The panic disorders market covered in this report is segmented -

1) By Type: Agoraphobia, Social Anxiety Disorder (SAD), Obsessive-Compulsive Disorder (OCD), Bipolar Disorder, Post-Traumatic Stress Disorder (PTSD), Major Depressive Disorder
2) By Treatment: Medication, Beta Blockers, Serotonin And Norepinephrine Reuptake Inhibitors (SNRIs), Benzodiazepines, Anti-Epilepsy, Other Treatments
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations
4) By End Use: Hospital Pharmacies, Retailer Pharmacies, Online Pharmacy Stores

Subsegments:
1) By Agoraphobia: Situational Agoraphobia, Non-Situational Agoraphobia
2) By Social Anxiety Disorder (SAD): Performance Anxiety, Generalized Social Anxiety
3) By Obsessive-Compulsive Disorder (OCD): Contamination OCD, Harm OCD, Checking OCD, Symmetry OCD
4) By Bipolar Disorder: Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder
5) By Post-Traumatic Stress Disorder (PTSD): Acute PTSD, Chronic PTSD, Complex PTSD
6) By Major Depressive Disorder: Recurrent Major Depressive Disorder, Single Episode Major Depressive Disorder

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13191&type=smp

Which Firms Dominate the Panic Disorders Market by Market Share and Revenue in 2025?
Major companies operating in the panic disorders market report are F. Hoffmann-La Roche Ltd., Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Baxter Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Bausch Health Companies Inc., H. Lundbeck A/S, Shionogi & Co Ltd., Recordati S.p.A, Neurocrine Biosciences Inc., Neuraxpharm, Actavis Plc., Noven Pharmaceuticals Inc., Sumitomo Pharma Co. Ltd., VistaGen Therapeutics, Valeant Pharmaceuticals International Inc., LIFECARE NEURO PRODUCTS LTD.

Which Regions Offer the Highest Growth Potential in the Panic Disorders Market?
North America was the largest region in the panic disorders market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the panic disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13191

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.